Page 11 - FLIPBOOK

International Metastatic Renal Cell Carcinoma Database Consortium

(IMDC) Criteria

• Prognostic risk groups

• Favorable-risk group: no

prognostic factors

• Intermediate group: one or two

prognostic factors

• Poor-risk group: three to six

prognostic factors

75 – 80% of mRCC patients are

Poor or Intermediate Risk

Graphic courtesy IKCC